![David-Alexandre Gros](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Patrimonio netto: 13 M $ in data 31/05/2026
David-Alexandre C.
Gros was the founder of Climb Bio, Inc., founded in 2018, where the title held was Director from 2018 to 2020.
Dr. Gros was the founder of Imbria Pharmaceuticals, Inc., founded in 2018, where the title held was Chairman & Chief Executive Officer from 2018 to 2020.
The current job is Chief Executive Officer & Director at Eledon Pharmaceuticals, Inc. starting in 2020.
Former jobs include President, Chief Operating & Financial Officer at Neurocrine Biosciences, Inc. in 2017; Chief Strategy Officer & Executive Vice President at Sanofi from 2013 to 2015; Associate Principal at McKinsey & Co., Inc. from 2002 to 2006; Chief Financial Officer at Alnylam Pharmaceuticals, Inc. from 2016 to 2017; Member-Supervisory Board at Saint Jean Groupe SA from 2014 to 2015; Principal at Centerview Partners LLC from 2009 to 2011; and Chief Strategy Officer at Sanofi from 2011 to 2015.
Education includes an undergraduate degree from Dartmouth College in 1995, a doctorate from The Johns Hopkins University School of Medicine in 1999, and an MBA from Harvard Business School in 2002.
| Società | Data | Numero di azioni | Valutazione | Data di valutazione |
|---|---|---|---|---|
SAINT JEAN GROUPE SA 15,62% | 07/05/2026 | 500.000 ( 15,62% ) | 13 M $ | 31/05/2026 |
| 31/03/2026 | 9.000 ( 0,01% ) | 34 290 $ | 31/05/2026 |
| Società | Posizione | Inizio |
|---|---|---|
| ELEDON PHARMACEUTICALS, INC. | Amministratore Delegato | 09/09/2020 |
| Società | Posizione | Fine |
|---|---|---|
| CLIMB BIO, INC. | Fondatore | 01/10/2020 |
Imbria Pharmaceuticals, Inc.
 Imbria Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a clinical stage company for the treatment of cardiovascular disease | Amministratore Delegato | 01/09/2020 |
| NEUROCRINE BIOSCIENCES, INC. | Presidente | 31/12/2017 |
| ALNYLAM PHARMACEUTICALS, INC. | Direttore Finanziario/CFO | 06/01/2017 |
| SAINT JEAN GROUPE | Direttore/Membro del Consiglio | 01/07/2015 |
Attive
Inattive
Società nel listino
Aziende private
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
| Aziende private | 12 |
|---|---|
Neurocrine Biosciences, Inc.
 Neurocrine Biosciences, Inc. BiotechnologyHealth Technology Discovers, develops and commercializes treatments for neurological, neuroendocrine and neuropsychiatric disorders | Health Technology |
Sanofi
 Sanofi Pharmaceuticals: MajorHealth Technology Engages in research, development and production of pharmaceuticals & vaccines | Health Technology |
McKinsey & Co., Inc.
 McKinsey & Co., Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a management consulting firm | Commercial Services |
Dartmouth College
 Dartmouth College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Saint Jean Groupe SA
 Saint Jean Groupe SA Food: Major DiversifiedConsumer Non-Durables Operates as an investment holding company with the interest in agro foods sector | Consumer Non-Durables |
Alnylam Pharmaceuticals, Inc.
 Alnylam Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes therapeutics based on RNA interference | Health Technology |
Centerview Partners LLC
 Centerview Partners LLC Investment Banks/BrokersFinance Provides brokerage services | Finance |
Harvard Business School
 Harvard Business School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The Johns Hopkins University School of Medicine
 The Johns Hopkins University School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Eledon Pharmaceuticals, Inc.
 Eledon Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceuticals | Health Technology |
Imbria Pharmaceuticals, Inc.
Imbria Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a clinical stage company for the treatment of cardiovascular disease | Commercial Services |
Eliem Therapeutics, Inc.
 Eliem Therapeutics, Inc. BiotechnologyHealth Technology Operates as clinical-stage biotechnology company focused on developing novel therapies for neuronal excitability disorders | Health Technology |
Seleziona la tua edizione
Tutte le informazioni finanziarie adattate in base al livello nazionale
